SLC15A1 and hepatocellular carcinoma: In addition, SLC15A1 was reported to be involved in the diagnosis and therapy of many cancers, including pancreatic cancer [22], bladder cancer [23], gliomas [24], hepatocellular carcinoma [14], renal-cell carcinoma [25], and lung adenocarcinoma [26].